Brevan Howard Capital Management LP Vanda Pharmaceuticals Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 18,288 shares of VNDA stock, worth $95,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,288
Previous 25,671
28.76%
Holding current value
$95,829
Previous $108,000
30.56%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
148Shares Held
49.6MCall Options Held
49.1KPut Options Held
107K-
Black Rock Inc. New York, NY8.14MShares$42.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.28MShares$22.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$17.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.37MShares$12.4 Million0.03% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$9.45 Million0.01% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $296M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...